Role of bone morphogenetic protein-7 in renal fibrosis

Frontiers in Physiology

Volumn 6, Issue MAR, 2015, Pages

  Li, Rui Xi ^a   Tang, Sydney C W ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

BMP 7; Chronic kidney disease; Cytokines; Inflammation; Renal fibrosis

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; OSTEOGENIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BIOACCUMULATION; BIODEGRADATION; CELL ACTIVATION; CELL INFILTRATION; CELL INTERACTION; CHRONIC KIDNEY DISEASE; DISEASE COURSE; DRUG EFFICACY; END STAGE RENAL DISEASE; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; FIBROGENESIS; HUMAN; INFLAMMATORY CELL; KIDNEY FIBROSIS; MOLECULAR INTERACTION; NEPHRITIS; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN SECRETION; REGULATORY MECHANISM;

EID: 84926472275     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2015.00114     Document Type: Article

References (101)

1. Abreu, J.G., Ketpura, N.I., Reversade, B., and De Robertis, E.M. (2002). Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta. Nat Cell Biol 4, 599-604. doi: 10.1038/ncb826.
2. Adler, S.G., Schwartz, S., Williams, M.E., Arauz-Pacheco, C., Bolton, W.K., Lee, T., Li, D., Neff, T.B., Urquilla, P.R., and Sewell, K.L. (2010). Phase 1 study of anti-CTGF monoclonal antibody in patients with diabetes and microalbuminuria. Clin J Am Soc Nephrol 5, 1420-1428. doi: 10.2215/CJN.09321209.
3. Aragno, M., Mastrocola, R., Alloatti, G., Vercellinatto, I., Bardini, P., Geuna, S., Catalano, M.G., Danni, O., and Boccuzzi, G. (2008). Oxidative stress triggers cardiac fibrosis in the heart of diabetic rats. Endocrinology 149, 380-388. doi: 10.1210/en.2007-0877.
4. Bi, W.R., Yang, C.Q., and Shi, Q. (2012). Transforming growth factor-beta1 induced epithelial-mesenchymal transition in hepatic fibrosis. Hepatogastroenterology 59, 1960-1963. doi: 10.5754/hge11750.
5. Boivin, G.P., O'toole, B.A., Orsmby, I.E., Diebold, R.J., Eis, M.J., Doetschman, T., and Kier, A.B. (1995). Onset and progression of pathological lesions in transforming growth factor-beta 1-deficient mice. Am J Pathol 146, 276-288.
6. Boor, P., Ostendorf, T., and Floege, J. (2010). Renal fibrosis: novel insights into mechanisms and therapeutic targets. Nat Rev Nephrol 6, 643-656. doi: 10.1038/nrneph.2010.120.
7. Border, W.A., and Noble, N.A. (1998). Evidence that TGF-beta should be a therapeutic target in diabetic nephropathy. Kidney Int 54, 1390-1391. doi: 10.1046/j.1523-1755.1998.00127.x.
8. Bottinger, E.P. (2007). TGF-beta in renal injury and disease. Semin Nephrol 27, 309-320. doi: 10.1016/j.semnephrol.2007.02.009.
9. Bramlage, C.P., Tampe, B., Koziolek, M., Maatouk, I., Bevanda, J., Bramlage, P., Ahrens, K., Lange, K., Schmid, H., Cohen, C.D., Kretzler, M., and Muller, G.A. (2010). Bone morphogenetic protein (BMP)-7 expression is decreased in human hypertensive nephrosclerosis. BMC Nephrol 11, 31. doi: 10.1186/1471-2369-11-31.
10. Branton, M.H., and Kopp, J.B. (1999). TGF-beta and fibrosis. Microbes Infect 1, 1349-1365.
11. Chan, W.L., Leung, J.C., Chan, L.Y., Tam, K.Y., Tang, S.C., and Lai, K.N. (2008). BMP-7 protects mesangial cells from injury by polymeric IgA. Kidney Int 74, 1026-1039. doi: 10.1038/ki.2008.209.
12. Cho, M.E., Smith, D.C., Branton, M.H., Penzak, S.R., and Kopp, J.B. (2007). Pirfenidone slows renal function decline in patients with focal segmental glomerulosclerosis. Clin J Am Soc Nephrol 2, 906-913. doi: 10.2215/CJN.01050207.
13. Chung, A.C., and Lan, H.Y. (2011). Chemokines in renal injury. J Am Soc Nephrol 22, 802-809. doi: 10.1681/ASN.2010050510.
14. Davies, M.R., Lund, R.J., and Hruska, K.A. (2003). BMP-7 is an efficacious treatment of vascular calcification in a murine model of atherosclerosis and chronic renal failure. J Am Soc Nephrol 14, 1559-1567.
15. Davies, M.R., Lund, R.J., Mathew, S., and Hruska, K.A. (2005). Low turnover osteodystrophy and vascular calcification are amenable to skeletal anabolism in an animal model of chronic kidney disease and the metabolic syndrome. J Am Soc Nephrol 16, 917-928. doi: 10.1681/ASN.2004100835.
16. De Petris, L., Hruska, K.A., Chiechio, S., and Liapis, H. (2007). Bone morphogenetic protein-7 delays podocyte injury due to high glucose. Nephrol Dial Transplant 22, 3442-3450. doi: 10.1093/ndt/gfm503.
17. Denton, C.P., Merkel, P.A., Furst, D.E., Khanna, D., Emery, P., Hsu, V.M., Silliman, N., Streisand, J., Powell, J., Akesson, A., Coppock, J., Hoogen, F., Herrick, A., Mayes, M.D., Veale, D., Haas, J., Ledbetter, S., Korn, J.H., Black, C.M., Seibold, J.R., Cat-192 Study, G., and Scleroderma Clinical Trials, C. (2007). Recombinant human anti-transforming growth factor beta1 antibody therapy in systemic sclerosis: a multicenter, randomized, placebo-controlled phase I/II trial of CAT-192. Arthritis Rheum 56, 323-333. doi: 10.1002/art.22289.
18. Diamond, J.R., Kees-Folts, D., Ding, G., Frye, J.E., and Restrepo, N.C. (1994). Macrophages, monocyte chemoattractant peptide-1, and TGF-beta 1 in experimental hydronephrosis. Am J Physiol 266, F926-933.
19. Dube, P.H., Almanzar, M.M., Frazier, K.S., Jones, W.K., Charette, M.F., and Paredes, A. (2004). Osteogenic Protein-1: gene expression and treatment in rat remnant kidney model. Toxicol Pathol 32, 384-392.
20. Dudas, P.L., Argentieri, R.L., and Farrell, F.X. (2009). BMP-7 fails to attenuate TGF-beta1-induced epithelial-to-mesenchymal transition in human proximal tubule epithelial cells. Nephrol Dial Transplant 24, 1406-1416. doi: 10.1093/ndt/gfn662.
21. Dudley, A.T., Lyons, K.M., and Robertson, E.J. (1995). A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. Genes Dev 9, 2795-2807.
22. Duffield, J.S. (2014). Cellular and molecular mechanisms in kidney fibrosis. J Clin Invest 124, 2299-2306. doi: 10.1172/JCI72267.
23. Eddy, A.A. (2014). Overview of the cellular and molecular basis of kidney fibrosis. Kidney Int Suppl (2011) 4, 2-8. doi: 10.1038/kisup.2014.2.
24. El-Dahr, S.S., Gee, J., Dipp, S., Hanss, B.G., Vari, R.C., and Chao, J. (1993). Upregulation of renin-angiotensin system and downregulation of kallikrein in obstructive nephropathy. Am J Physiol 264, F874-881.
25. Ferenbach, D., Kluth, D.C., and Hughes, J. (2007). Inflammatory cells in renal injury and repair. Semin Nephrol 27, 250-259. doi: 10.1016/j.semnephrol.2007.02.001.
26. Fern, R.J., Yesko, C.M., Thornhill, B.A., Kim, H.S., Smithies, O., and Chevalier, R.L. (1999). Reduced angiotensinogen expression attenuates renal interstitial fibrosis in obstructive nephropathy in mice. J Clin Invest 103, 39-46. doi: 10.1172/JCI4236.
27. Gould, S.E., Day, M., Jones, S.S., and Dorai, H. (2002). BMP-7 regulates chemokine, cytokine, and hemodynamic gene expression in proximal tubule cells. Kidney Int 61, 51-60. doi: 10.1046/j.1523-1755.2002.00103.x.
28. Gressner, O.A., and Gressner, A.M. (2008). Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases. Liver Int 28, 1065-1079. doi: 10.1111/j.1478-3231.2008.01826.x.
29. Guha, M., Xu, Z.G., Tung, D., Lanting, L., and Natarajan, R. (2007). Specific down-regulation of connective tissue growth factor attenuates progression of nephropathy in mouse models of type 1 and type 2 diabetes. FASEB J 21, 3355-3368. doi: 10.1096/fj.06-6713com.
30. Holmbeck, K., Bianco, P., Caterina, J., Yamada, S., Kromer, M., Kuznetsov, S.A., Mankani, M., Robey, P.G., Poole, A.R., Pidoux, I., Ward, J.M., and Birkedal-Hansen, H. (1999).MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 99, 81-92.
31. Hruska, K.A., Guo, G., Wozniak, M., Martin, D., Miller, S., Liapis, H., Loveday, K., Klahr, S., Sampath, T.K., and Morrissey, J. (2000). Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction. Am J Physiol Renal Physiol 279, F130-143.
32. Hruska, K.A., Mathew, S., and Saab, G. (2005). Bone morphogenetic proteins in vascular calcification. Circ Res 97, 105-114. doi: 10.1161/01.RES.00000175571.53833.6c.
33. Ikeda, Y., Jung, Y.O., Kim, H., Oda, T., Lopez-Guisa, J., Maruvada, R., Diamond, D.L., Martin, K.J., Wing, D., Cai, X., and Eddy, A.A. (2004). Exogenous bone morphogenetic protein-7 fails to attenuate renal fibrosis in rats with overload proteinuria. Nephron Exp Nephrol 97, e123-135. doi: 10.1159/000079177.
34. Kawakami, T., Mimura, I., Shoji, K., Tanaka, T., and Nangaku, M. (2014). Hypoxia and fibrosis in chronic kidney disease: crossing at pericytes. Kidney Int Suppl (2011) 4, 107-112. doi: 10.1038/kisup.2014.20.
35. Kim, J., Seok, Y.M., Jung, K.J., and Park, K.M. (2009). Reactive oxygen species/oxidative stress contributes to progression of kidney fibrosis following transient ischemic injury in mice. Am J Physiol Renal Physiol 297, F461-470. doi: 10.1152/ajprenal.90735.2008.
36. Kopp, J.B., Factor, V.M., Mozes, M., Nagy, P., Sanderson, N., Bottinger, E.P., Klotman, P.E., and Thorgeirsson, S.S. (1996). Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease. Lab Invest 74, 991-1003.
37. Lan, H.Y. (2003). Tubular epithelial-myofibroblast transdifferentiation mechanisms in proximal tubule cells. Curr Opin Nephrol Hypertens 12, 25-29. doi: 10.1097/01.mnh.0000049812.98789.97.
38. Lan, H.Y. (2011). Diverse roles of TGF-beta/Smads in renal fibrosis and inflammation. Int J Biol Sci 7, 1056-1067.
39. Leask, A., and Abraham, D.J. (2004). TGF-beta signaling and the fibrotic response. FASEB J 18, 816-827. doi: 10.1096/fj.03-1273rev.
40. Leask, A., and Abraham, D.J. (2006). All in the CCN family: essential matricellular signaling modulators emerge from the bunker. J Cell Sci 119, 4803-4810. doi: 10.1242/jcs.03270.
41. Lee, H., Overall, C.M., Mcculloch, C.A., and Sodek, J. (2006). A critical role for the membrane-type 1 matrix metalloproteinase in collagen phagocytosis. Mol Biol Cell 17, 4812-4826. doi: 10.1091/mbc.E06-06-0486.
42. Lee, M.J., Yang, C.W., Jin, D.C., Chang, Y.S., Bang, B.K., and Kim, Y.S. (2003). Bone morphogenetic protein-7 inhibits constitutive and interleukin-1 beta-induced monocyte chemoattractant protein-1 expression in human mesangial cells: role for JNK/AP-1 pathway. J Immunol 170, 2557-2563.
43. Lee, S.Y., Kim, S.I., and Choi, M.E. (2014). Therapeutic targets for treating fibrotic kidney diseases. Transl Res. doi: 10.1016/j.trsl.2014.07.010.
44. Li, R.X., Yiu, W.H., Wu, H.J., Wong, D.W., Chan, L.Y., Lin, M., Leung, J.C., Lai, K.N., and Tang, S.C. (2015). BMP7 reduces inflammation and oxidative stress in diabetic tubulopathy. Clin Sci (Lond) 128, 269-280. doi: 10.1042/CS20140401.
45. Lim, A.I., Chan, L.Y., Tang, S.C., Yiu, W.H., Li, R., Lai, K.N., and Leung, J.C. (2014). BMP-7 represses albumin-induced chemokine synthesis in kidney tubular epithelial cells through destabilization of NF-kappaB-inducing kinase. Immunol Cell Biol 92, 427-435. doi: 10.1038/icb.2013.106.
46. Liu, Y. (2006). Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int 69, 213-217. doi: 10.1038/sj.ki.5000054.
47. Luo, D.D., Phillips, A., and Fraser, D. (2010). Bone morphogenetic protein-7 inhibits proximal tubular epithelial cell Smad3 signaling via increased SnoN expression. Am J Pathol 176, 1139-1147. doi: 10.2353/ajpath.2010.090459.
48. Luo, G., Hofmann, C., Bronckers, A.L., Sohocki, M., Bradley, A., and Karsenty, G. (1995). BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. Genes Dev 9, 2808-2820.
49. Mack, M., and Yanagita, M. (2015). Origin of myofibroblasts and cellular events triggering fibrosis. Kidney Int 87, 297-307. doi: 10.1038/ki.2014.287.
50. Mcmorrow, T., Gaffney, M.M., Slattery, C., Campbell, E., and Ryan, M.P. (2005). Cyclosporine A induced epithelial-mesenchymal transition in human renal proximal tubular epithelial cells. Nephrol Dial Transplant 20, 2215-2225. doi: 10.1093/ndt/gfh967.
51. Mead, A.L., Wong, T.T., Cordeiro, M.F., Anderson, I.K., and Khaw, P.T. (2003). Evaluation of anti-TGF-beta2 antibody as a new postoperative anti-scarring agent in glaucoma surgery. Invest Ophthalmol Vis Sci 44, 3394-3401.
52. Meng, X.M., Chung, A.C., and Lan, H.Y. (2013). Role of the TGF-beta/BMP-7/Smad pathways in renal diseases. Clin Sci (Lond) 124, 243-254. doi: 10.1042/CS20120252.
53. Meng, X.M., Nikolic-Paterson, D.J., and Lan, H.Y. (2014). Inflammatory processes in renal fibrosis. Nat Rev Nephrol 10, 493-503. doi: 10.1038/nrneph.2014.114.
54. Mitu, G.M., Wang, S., and Hirschberg, R. (2007). BMP7 is a podocyte survival factor and rescues podocytes from diabetic injury. Am J Physiol Renal Physiol 293, F1641-1648. doi: 10.1152/ajprenal.00179.2007.
55. Morrissey, J., Hruska, K., Guo, G., Wang, S., Chen, Q., and Klahr, S. (2002). Bone morphogenetic protein-7 improves renal fibrosis and accelerates the return of renal function. J Am Soc Nephrol 13 Suppl 1, S14-21.
56. Moustakas, A., and Heldin, C.H. (2012). Induction of epithelial-mesenchymal transition by transforming growth factor beta. Semin Cancer Biol 22, 446-454. doi: 10.1016/j.semcancer.2012.04.002.
57. Munoz-Felix, J.M., Oujo, B., and Lopez-Novoa, J.M. (2014). The role of endoglin in kidney fibrosis. Expert Rev Mol Med 16, e18. doi: 10.1017/erm.2014.20.
58. Nathan, C., and Ding, A. (2010). Nonresolving inflammation. Cell 140, 871-882. doi: 10.1016/j.cell.2010.02.029.
59. Nguyen, T.Q., Roestenberg, P., Van Nieuwenhoven, F.A., Bovenschen, N., Li, Z., Xu, L., Oliver, N., Aten, J., Joles, J.A., Vial, C., Brandan, E., Lyons, K.M., and Goldschmeding, R.(2008a). CTGF inhibits BMP-7 signaling in diabetic nephropathy. J Am Soc Nephrol 19, 2098-2107. doi: 10.1681/ASN.2007111261.
60. Nguyen, T.Q., Tarnow, L., Jorsal, A., Oliver, N., Roestenberg, P., Ito, Y., Parving, H.H., Rossing, P., Van Nieuwenhoven, F.A., and Goldschmeding, R. (2008b). Plasma connective tissue growth factor is an independent predictor of end-stage renal disease and mortality in type 1 diabetic nephropathy. Diabetes Care 31, 1177-1182. doi: 10.2337/dc07-2469.
61. Nie, J., and Hou, F.F. (2012). Role of reactive oxygen species in the renal fibrosis. Chin Med J (Engl) 125, 2598-2602.
62. Poli, G. (2000). Pathogenesis of liver fibrosis: role of oxidative stress. Mol Aspects Med 21, 49-98.
63. Ramachandrarao, S.P., Zhu, Y., Ravasi, T., Mcgowan, T.A., Toh, I., Dunn, S.R., Okada, S., Shaw, M.A., and Sharma, K. (2009). Pirfenidone is renoprotective in diabetic kidney disease. J Am Soc Nephrol 20, 1765-1775. doi: 10.1681/ASN.2008090931.
64. Ricardo, S.D., Van Goor, H., and Eddy, A.A. (2008). Macrophage diversity in renal injury and repair. J Clin Invest 118, 3522-3530. doi: 10.1172/JCI36150.
65. Rocher, C., Singla, R., Singal, P.K., Parthasarathy, S., and Singla, D.K. (2012). Bone morphogenetic protein 7 polarizes THP-1 cells into M2 macrophages. Can J Physiol Pharmacol 90, 947-951. doi: 10.1139/y2012-102.
66. Sanderson, N., Factor, V., Nagy, P., Kopp, J., Kondaiah, P., Wakefield, L., Roberts, A.B., Sporn, M.B., and Thorgeirsson, S.S. (1995). Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci U S A 92, 2572-2576.
67. Sanford, L.P., Ormsby, I., Gittenberger-De Groot, A.C., Sariola, H., Friedman, R., Boivin, G.P., Cardell, E.L., and Doetschman, T. (1997). TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. Development 124, 2659-2670.
68. Schroder, K., and Tschopp, J. (2010). The inflammasomes. Cell 140, 821-832. doi: 10.1016/j.cell.2010.01.040.
69. Sharma, K., Ix, J.H., Mathew, A.V., Cho, M., Pflueger, A., Dunn, S.R., Francos, B., Sharma, S., Falkner, B., Mcgowan, T.A., Donohue, M., Ramachandrarao, S., Xu, R., Fervenza, F.C., and Kopp, J.B. (2011). Pirfenidone for diabetic nephropathy. J Am Soc Nephrol 22, 1144-1151. doi: 10.1681/ASN.2010101049.
70. Simon, M., Maresh, J.G., Harris, S.E., Hernandez, J.D., Arar, M., Olson, M.S., and Abboud, H.E. (1999). Expression of bone morphogenetic protein-7 mRNA in normal and ischemic adult rat kidney. Am J Physiol 276, F382-389.
71. Singh, D.K., Winocour, P., and Farrington, K. (2011). Oxidative stress in early diabetic nephropathy: fueling the fire. Nat Rev Endocrinol 7, 176-184. doi: 10.1038/nrendo.2010.212.
72. Sugimoto, H., Grahovac, G., Zeisberg, M., and Kalluri, R. (2007). Renal fibrosis and glomerulosclerosis in a new mouse model of diabetic nephropathy and its regression by bone morphogenic protein-7 and advanced glycation end product inhibitors. Diabetes 56, 1825-1833. doi: 10.2337/db06-1226.
73. Sun, L., Guo, C., Liu, D., Zhao, Y., Zhang, Y., Song, Z., Han, H., Chen, D., and Zhao, Y. (2011). Protective effects of bone morphogenetic protein 7 against amyloid-beta induced neurotoxicity in PC12 cells. Neuroscience 184, 151-163. doi: 10.1016/j.neuroscience.2011.03.059.
74. Tacke, F., Gabele, E., Bataille, F., Schwabe, R.F., Hellerbrand, C., Klebl, F., Straub, R.H., Luedde, T., Manns, M.P., Trautwein, C., Brenner, D.A., Scholmerich, J., and Schnabl, B. (2007).Bone morphogenetic protein 7 is elevated in patients with chronic liver disease and exerts fibrogenic effects on human hepatic stellate cells. Dig Dis Sci 52, 3404-3415. doi: 10.1007/s10620-007-9758-8.
75. Tan, X.Y., Zheng, F.L., Zhou, Q.G., Duan, L., and Li, Y. (2005). [Effect of bone morphogenetic protein-7 on monocyte chemoattractant protein-1 induced epithelial-myofibroblast transition and TGF-beta1-Smad 3 signaling pathway of HKC cells]. Zhonghua Yi Xue Za Zhi 85, 2607-2612.
76. Tsai, M.J., Weng, C.F., Shyue, S.K., Liou, D.Y., Chen, C.H., Chiu, C.W., Yang, T.H., Pan, H.A., Liao, R.I., Kuo, H.S., Huang, M.C., Huang, W.C., Hoffer, B.J., and Cheng, H. (2007).Dual effect of adenovirus-mediated transfer of BMP7 in mixed neuron-glial cultures: neuroprotection and cellular differentiation. J Neurosci Res 85, 2950-2959. doi: 10.1002/jnr.21395.
77. Veerasamy, M., Nguyen, T.Q., Motazed, R., Pearson, A.L., Goldschmeding, R., and Dockrell, M.E. (2009). Differential regulation of E-cadherin and alpha-smooth muscle actin by BMP 7 in human renal proximal tubule epithelial cells and its implication in renal fibrosis. Am J Physiol Renal Physiol 297, F1238-1248. doi: 10.1152/ajprenal.90539.2008.
78. Vernon, M.A., Mylonas, K.J., and Hughes, J. (2010). Macrophages and renal fibrosis. Semin Nephrol 30, 302-317. doi: 10.1016/j.semnephrol.2010.03.004.
79. Visse, R., and Nagase, H. (2003). Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92, 827-839. doi: 10.1161/01.RES.0000070112.80711.3D.
80. Vukicevic, S., Basic, V., Rogic, D., Basic, N., Shih, M.S., Shepard, A., Jin, D., Dattatreyamurty, B., Jones, W., Dorai, H., Ryan, S., Griffiths, D., Maliakal, J., Jelic, M., Pastorcic, M., Stavljenic, A., and Sampath, T.K. (1998). Osteogenic protein-1 (bone morphogenetic protein-7) reduces severity of injury after ischemic acute renal failure in rat. J Clin Invest 102, 202-214. doi: 10.1172/JCI2237.
81. Wang, S., Chen, Q., Simon, T.C., Strebeck, F., Chaudhary, L., Morrissey, J., Liapis, H., Klahr, S., and Hruska, K.A. (2003). Bone morphogenic protein-7 (BMP-7), a novel therapy for diabetic nephropathy. Kidney Int 63, 2037-2049. doi: 10.1046/j.1523-1755.2003.00035.x.
82. Wang, S., De Caestecker, M., Kopp, J., Mitu, G., Lapage, J., and Hirschberg, R. (2006). Renal bone morphogenetic protein-7 protects against diabetic nephropathy. J Am Soc Nephrol 17, 2504-2512. doi: 10.1681/ASN.2006030278.
83. Wang, S., and Hirschberg, R. (2003). BMP7 antagonizes TGF-beta -dependent fibrogenesis in mesangial cells. Am J Physiol Renal Physiol 284, F1006-1013. doi: 10.1152/ajprenal.00382.2002.
84. Wang, S., and Hirschberg, R. (2004). Bone morphogenetic protein-7 signals opposing transforming growth factor beta in mesangial cells. J Biol Chem 279, 23200-23206. doi: 10.1074/jbc.M311998200.
85. Wang, S.N., Lapage, J., and Hirschberg, R. (2001). Loss of tubular bone morphogenetic protein-7 in diabetic nephropathy. J Am Soc Nephrol 12, 2392-2399.
86. Wang, Z., Zhao, J., Zhang, J., Wei, J., Zhang, J., and Huang, Y. (2010). Protective effect of BMP-7 against aristolochic acid-induced renal tubular epithelial cell injury. Toxicol Lett 198, 348-357. doi: 10.1016/j.toxlet.2010.07.018.
87. Xiao, H.Q., Shi, W., Zhang, Y., and Liang, Y.Z. (2009). [Effect of bone morphogenic protein 7 on nephrin expression and distribution in diabetic rat kidneys]. Nan Fang Yi Ke Da Xue Xue Bao 29, 671-675.
88. Xu, Y., Wan, J., Jiang, D., and Wu, X. (2009). BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition in human renal proximal tubular epithelial cells. J Nephrol 22, 403-410.
89. Xu, Y., Wan, J., Jiang, D., and Wu, X. (2010). BMP-7 blocks the cyclosporine-A-induced epithelial-to-mesenchymal transition in renal tubular epithelial cells. Nephron Exp Nephrol 114, e23-31. doi: 10.1159/000245063.
90. Yang, Q., Han, B., Xie, R.J., and Cheng, M.L. (2007). [Changes of bone morphogenetic protein-7 and inhibitory Smad expression in streptozotocin-induced diabetic nephropathy rat kidney]. Sheng Li Xue Bao 59, 190-196.
91. Yeh, C.H., Chang, C.K., Cheng, M.F., Lin, H.J., and Cheng, J.T. (2009). The antioxidative effect of bone morphogenetic protein-7 against high glucose-induced oxidative stress in mesangial cells. Biochem Biophys Res Commun 382, 292-297. doi: 10.1016/j.bbrc.2009.03.011.
92. Yokoi, H., Mukoyama, M., Nagae, T., Mori, K., Suganami, T., Sawai, K., Yoshioka, T., Koshikawa, M., Nishida, T., Takigawa, M., Sugawara, A., and Nakao, K. (2004).Reduction in connective tissue growth factor by antisense treatment ameliorates renal tubulointerstitial fibrosis. J Am Soc Nephrol 15, 1430-1440.
93. Yoo, K.H., Norwood, V.F., El-Dahr, S.S., Yosipiv, I., and Chevalier, R.L. (1997). Regulation of angiotensin II AT1 and AT2 receptors in neonatal ureteral obstruction. Am J Physiol 273, R503-509.
94. You, L., and Kruse, F.E. (2002). Differential effect of activin A and BMP-7 on myofibroblast differentiation and the role of the Smad signaling pathway. Invest Ophthalmol Vis Sci 43, 72-81.
95. Zeisberg, M., Bottiglio, C., Kumar, N., Maeshima, Y., Strutz, F., Muller, G.A., and Kalluri, R.(2003a). Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models. Am J Physiol Renal Physiol 285, F1060-1067. doi: 10.1152/ajprenal.00191.2002.
96. Zeisberg, M., Hanai, J., Sugimoto, H., Mammoto, T., Charytan, D., Strutz, F., and Kalluri, R. (2003b). BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 9, 964-968. doi: 10.1038/nm888.
97. Zeisberg, M., Shah, A.A., and Kalluri, R. (2005). Bone morphogenic protein-7 induces mesenchymal to epithelial transition in adult renal fibroblasts and facilitates regeneration of injured kidney. J Biol Chem 280, 8094-8100. doi: 10.1074/jbc.M413102200.
98. Zhang, J.J., Bledsoe, G., Kato, K., Chao, L., and Chao, J. (2004). Tissue kallikrein attenuates salt-induced renal fibrosis by inhibition of oxidative stress. Kidney Int 66, 722-732. doi: 10.1111/j.1523-1755.2004.00794.x.
99. Zhang, X.L., Selbi, W., De La Motte, C., Hascall, V., and Phillips, A.O. (2005). Bone morphogenic protein-7 inhibits monocyte-stimulated TGF-beta1 generation in renal proximal tubular epithelial cells. J Am Soc Nephrol 16, 79-89. doi: 10.1681/ASN.2004050395.
100. Zhao, W., Chen, S.S., Chen, Y., Ahokas, R.A., and Sun, Y. (2008a). Kidney fibrosis in hypertensive rats: role of oxidative stress. Am J Nephrol 28, 548-554. doi: 10.1159/000115289.
101. Zhao, W., Zhao, T., Chen, Y., Ahokas, R.A., and Sun, Y. (2008b). Oxidative stress mediates cardiac fibrosis by enhancing transforming growth factor-beta1 in hypertensive rats. Mol Cell Biochem 317, 43-50. doi: 10.1007/s11010-008-9803-8.